Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001690585-16-000001
Filing Date
2016-11-23
Accepted
2016-11-23 13:12:34
Documents
1
Effectiveness Date
2016-11-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9692
  Complete submission text file 0001690585-16-000001.txt   10752
Mailing Address 245 FIRST STREET 4TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET 4TH FLOOR CAMBRIDGE MA 02142 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-275074 | Film No.: 162015837